Reacta Healthcare announces successful completion of £1m food allergy paediatric diagnostics project substantially funded by Innovate UK.
Reacta Healthcare, a clinical diagnostic company dedicated to providing innovative diagnostics for life-threatening food allergies,...
Reacta Healthcare strengthens Advisory Board in preparation for significant R&D and regulatory activities.
Reacta Healthcare Press Release – 30 January 2024 Reacta Healthcare is a diagnostics company...
Simon Thelwall-Jones appointed as CFO
Reacta Healthcare Press Release – 23 November 2023 Reacta Healthcare bolsters Board & Executive...
Reacta Healthcare appoints Kevin Hawkins as Head of Regulatory Affairs
Reacta Healthcare appoints Kevin Hawkins as Head of Regulatory Affairs 20 June 2023, Deeside, United...
New partnership with FAACT – Food Allergy & Anaphylaxis Connection Team
Reacta Healthcare is proud to partner with FAACT to support the needs of the food...
First major milestone reached for Reacta Healthcare £1m Innovate UK funded project
Reacta Healthcare is helping combat food allergies amongst paediatrics, addressing the unmet need for greater...
Senior hire to cement 2023 growth plans at Reacta Healthcare
Reacta Healthcare has appointed a new quality control manager to further expand and develop its...
My time at MEDICA 2022
By Dr Martin Wickham, Chief Commercial Officer, Reacta Healthcare Last month I had the...
Development Bank of Wales ramping up tech equity deals since the lockdown
The Development Bank of Wales has invested £2.4m of equity into ten of Wales’ most...
Reacta Healthcare secures first US patent
Reacta Healthcare, based in Deeside North Wales, has secured its first US patent, expanding patents...
Praetura Ventures leads £2.9m investment in food allergy diagnostic firm
Praetura Ventures, the Manchester-based VC firm, has led a £2.9m funding round to support a...
UK Food Allergy Diagnostic company, Reacta Biotech, achieves MHRA GMP licence
Pursuant to a capital raise in 2020, Reacta has achieved its goal of securing an...
Reacta Biotech making progress on peanut diagnostic product
Deeside-based Reacta Biotech is on course to secure a market authorisation for its peanut diagnostic...
Reacta Healthcare Awarded Major Biomedical Catalyst Grant to develop Paediatric Food allergy diagnostics
The £1 million grant will support the development of the first Oral Food Challenges (OFCs)...
UK food allergy diagnostic company, Reacta Biotech raises £1.25m to continue expansion plans
We share relevant third party stories on our website. This release was written and issued...